ifabotuzumab (KB004) / Humanigen, Olivia Newton-John Cancer Research Institute  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ifabotuzumab (KB004) / Humanigen
NCT01211691: Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Suspended
1/2
120
US, RoW
KB004, Monoclonal Antibody
Humanigen, Inc.
Myelodysplastic Syndrome (MDS), Myelofibrosis (MF)
07/16
12/16

Download Options